News

Innovation alliance unveils new name and strategic plan for Western Virginia

A strategic alliance has a new name — Verge — and a new vision of acting as the front door for an innovation economy that stretches from Lynchburg to the New River Valley.

Formed last year, the alliance is a joint mission of the Valleys Innovation Council, the Roanoke-Blacksburg Technology Council and the Regional Accelerator and Mentoring Program, known as RAMP.

At a virtual news conference Monday, organizers said the unified strength of the three organizations will help solidify connections and better leverage emerging opportunities for the region’s technologists, innovators and entrepreneurs.

Verge will focus on the technology and life sciences innovation ecosystem in the GO Virginia Region 2, a sprawling span of the state that includes the Roanoke and New River valleys, the Alleghany Highlands and the Lynchburg region.

“What is happening in technology in this part of Virginia is really exciting,” CEO Greg Feldmann said in a statement.

“By aligning the efforts of three distinct but synergistic entities, we will all more effectively develop external resourcing, more efficiently implement new programs ensuring each reaches the right audiences at the right moments and in the right contexts to provide maximum value.

“It’s all about comprehensively supporting the many people and organizations who are investing in and shaping the economic future of our region.”

While collaborating in the newly defined joint mission, the three organizations will continue their day-to-day operations under the same leadership.

Recent News

04/23/2024

AMPEL BioSolutions Selected as Member of Prestigious Federal Health Innovation ARPA-H Network

AMPEL BioSolutions has been selected as a member – or “spoke” – of the Customer Experience Hub of ARPANET-H, a prestigious nationwide health innovation network launched by the Advanced Research Projects Agency for Health (ARPA-H).  This national effort is designed to accelerate commercialization of health breakthroughs for populations that urgently need them. The Customer Experience Hub in Dallas joins Boston

04/19/2024

ivWatch prevents IV leakage events at Frimley Health

Frimley Health NHS Foundation Trust has found that 100% of IV leakage incidents were prevented by a proprietary patient monitoring system from ivWatch, which could potentially save patients the pain or discomfort of adverse IV events. The initial two-week phase of the study, which was published in the British Journal of Nursing, found that continuous

04/17/2024

U.S. Department of Health and Human Services Awards Kaléo with Contract to Develop Next Generation Organophosphate Nerve Agent Poisoning Countermeasure

Kaléo, a privately-held U.S. pharmaceutical company today announced their selection by the Biomedical Advanced Research and Development Authority (BARDA), part of Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), to develop the latest generation pralidoxime chloride auto-injector as a countermeasure against organophosphate or nerve agent poisoning.